Board of Directors’ President, Helen Currier honored with highest nursing award

Helen Currier, BSN, RN, CNN, CNEP, director of Renal and Pheresis Services at Texas Children’s Hospital in Houston was awarded the prestigious Barbara Prowant Lifetime Achievement Award in Nephrology Nursing during the 32nd Annual Dialysis Conference held on February 25-28 in San Antonio, Texas. The award recognizes nephrology nurses who have made significant contributions to the advancement of nephrology nursing through clinical care, education, and research.

Currier, who was mentored by former award winners including Barbara Prowant, is a national and international consultant, author and lecturer in pediatric nephrology nursing. Her research interests include pediatric renal replacement therapies, issues facing chronically ill children, quality of life for pediatric chronic kidney disease patients, health care environmental design and the healing arts. In 2010, she was inducted as one of twenty inaugural distinguished fellows for the Society for the Arts in Healthcare.

Currier came to Texas Children’s Hospital in 1976 to serve as a charge nurse for a 20-bed pediatric cardiology unit and later as charge nurse and unit teacher in an 18-bed PICU. By 1980, she had moved into the Dialysis unit of Texas Children’s, where she has held many leadership jobs. During her 36-year career, she has authored or co-authored 17 abstracts, 27 publications and has represented Texas Children’s Hospital at numerous national and international conferences around the world. A highlight has been her interface with nephrology nurse colleagues in South Africa where in 2010 she was awarded an Honorary Life Membership of the Renal Care Society of South Africa in recognition of devotion and contribution of exceptional merit to the Society.

Currier holds varied interests in the medical arts. She is active in 8 organizations and serves on the Boards of the National Renal Administrators’ Association, the Society for the Arts in Healthcare and the Houston Boychoir.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply

Your email address will not be published. Required fields are marked *